REGN vs TOST · P/E 14, rev $14.34B vs P/E 161, rev $4.96B
Regeneron Pharmaceuticals Inc (REGN) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Toast Inc (TOST) is a software - infrastructure company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TOST revenue for 2024-12-31 was $4.96B. Net income was $19.0M. Revenue was up 28.3% from 2023-12-31 to 2024-12-31. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the REGN and TOST stock pages for the full models.
Not investment advice.